Company / Shares Outstanding
Vistagen Therapeutics, Inc. Shares Outstanding History
FY2011-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
42.6M
FY2021
5-year range
1.6M / 42.6M
FY2017-FY2021
Trend
+736.1%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding changed +736% YoY in FY2021, a notable deviation from the 5-year average annual change of +209%.
Based on SEC 10-K filings.
42622965.00 in FY2021 with a 10-year CAGR of +23.3%.
Increased from 1559483.00 to 42622965.00 over the past 4 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +103.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- +23.3%
Key checks
Key Insights
- In FY2021, shares outstanding increased 736.1% year-over-year.
- Lowest shares outstanding in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | 42.6M | +736.1% |
| FY2018 | 5.1M | +226.9% |
| FY2017 | 1.6M | -91.4% |
| FY2014 | 18.1M | +63.1% |
| FY2012 | 11.1M | +111.9% |
| FY2011 | 5.2M | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026